drugset / Trial / NCT04396795

Safety and Efficacy of Autologous Platelet-Rich Plasma for Erectile Dysfunction.

NCT04396795

Phase 2 Completed 61 enrolled University of Miami
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to evaluate changes in vascular parameters and International Index of Erectile Function (IIEF) scores with the administration of Platelet Rich Plasma (PRP) to participants with Erectile Dysfunction (ED)

Timeline

Start
2020-05-21
Primary completion
2023-01-23
Completion
2023-04-18

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Platelet Rich Plasma Other / unclassified 5 ml Other

Indications